Literature DB >> 10805482

Epidemiology of cardiovascular disease in systemic lupus erythematosus.

C Aranow1, E M Ginzler.   

Abstract

Awareness of the impact of cardiovascular disease on the late morbidity and mortality in patients with Systemic Lupus Erythematosus (SLE) is increasing. Clinical events secondary to accelerated atherosclerosis have been documented in lupus cohorts across the globe. We review the history and epidemiology of cardiovascular disease in patients with SLE.

Entities:  

Mesh：

Year:  2000        PMID： 10805482     DOI： 10.1191/096120300678828208

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


  30 in total

Review 1.  [Glucocorticoid therapy in collagen diseases diseases].

Authors:  L Unger; M Kayser; M Enderlein; K Manger; H Nüsslein
Journal:  Z Rheumatol       Date:  2005-04       Impact factor: 1.372

2.  Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Safia Ogbi; Takayuki Matsumoto; R Clinton Webb
Journal:  Pharmacol Res       Date:  2016-09-14       Impact factor: 7.658

Review 3.  Cardiac involvement in systemic autoimmune diseases.

Authors:  Piersandro Riboldi; Maria Gerosa; Cristina Luzzana; Luca Catelli
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

4.  NMR based serum metabolomics reveals a distinctive signature in patients with Lupus Nephritis.

Authors:  Anupam Guleria; Avadhesh Pratap; Durgesh Dubey; Atul Rawat; Smriti Chaurasia; Edavalath Sukesh; Sanat Phatak; Sajal Ajmani; Umesh Kumar; Chunni Lal Khetrapal; Paul Bacon; Ramnath Misra; Dinesh Kumar
Journal:  Sci Rep       Date:  2016-10-14       Impact factor: 4.379

Review 5.  Atherosclerosis in autoimmune diseases.

Authors:  Eiji Matsuura; Kazuko Kobayashi; Luis R Lopez
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

6.  Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Safia Ogbi; Babak Baban; Jennifer C Sullivan; Takayuki Matsumoto; R Clinton Webb
Journal:  Cardiovasc Res       Date:  2015-04-24       Impact factor: 10.787

7.  Chloroquine Suppresses the Development of Hypertension in Spontaneously Hypertensive Rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Babak Baban; Takayuki Matsumoto; R Clinton Webb
Journal:  Am J Hypertens       Date:  2016-09-13       Impact factor: 2.689

8.  Subclinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indices.

Authors:  S Fadda; H Nassar; S M Gamal; H Al-azizi
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

Review 9.  Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.

Authors:  Luis R Lopez; Kazuko Kobayashi; Yukana Matsunami; Eiji Matsuura
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

10.  Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare.

Authors:  Emmanuel Ribeiro; Thomas Cressend; Pierre Duffau; Marieke Grenouillet-Delacre; Marie Rouanet-Larivière; Anne Vital; Maïté Longy-Boursier; Patrick Mercié
Journal:  Case Rep Med       Date:  2010-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.